Previous 10 | Next 10 |
2023-06-30 12:16:06 ET Superlatus has signed a definitive agreement to be acquired by TRxADE HEALTH ( NASDAQ: MEDS ), a pharmaceutical exchange platform provider. Upon closing of the Merger, shareholders of Superlatus will receive an aggregate of 173,463 shares of MEDS sto...
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, announced today that it has signed a definitive agreement to be acquired by TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE...
2023-06-28 13:55:47 ET Gainers: Centogene ( CNTG ) +45% . Joby Aviation ( JOBY ) +41% . Kaleyra ( KLR ) +39% . GEN Restaurant Group ( GENK ) +27% . Lilium ( LILM ) +26% . IonQ ( IONQ ) +22% . Beneficient ( BENF ...
TRxADE Health (NASDAQ: MEDS) , a pharmaceutical exchange platform provider, previously entered a binding letter of intent (“LOI”) to acquire Superlatus Inc., a U.S.-based holding company of food products and distribution capabilities. Subject to customary conditions, the merger was ...
2023-06-27 08:24:09 ET Lordstown Motors ( RIDE ) -61% after bankruptcy filing, Foxconn lawsuit . TRxADE HEALTH ( MEDS ) -14%. Adicet Bio ( ACET ) -12% on phase 1 data for non-Hodgkin's lymphoma asset . Microbot Medical ( MBOT ) -12% anno...
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”) (“the Company), a U.S.-based holding company of food products and distribution capabilities, which on June 23, 2023 announced the signing of a binding letter of intent (the “LOI”) to be ...
Eat Well Group (CSE: EWG) (OTC: EWGFF) , a leading plant-based food ingredient and CPG company, has entered into a definitive membership interest purchase agreement (“MIPA”) as part of a NASDAQ merger with TRxADE Health Inc. (NASDAQ: MEDS) . The MIPA outlines the sale o...
2023-06-26 08:27:27 ET TRxADE HEALTH ( MEDS ) +74% . MoonLake Immunotherapeutics ( MLTX ) +56% . Eco Wave Power Global ( WAVE ) +24% . Adamis Pharmaceuticals ( ADMP ) +18% Announces NIH Grant Funding for the Treatment of Alcohol Use Di...
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June 23, 2023, 8:05 U.S. Eastern Time, entitled “Superlatus, Inc. to Combine with ...
2023-06-23 13:00:34 ET TRxADE HEALTH ( NASDAQ: MEDS ) said on Friday that it had signed a binding letter of intent to acquire Superlatus. After the closing of the deal, Superlatus shareholders will receive 30.8M shares of MEDS, valued at $7.30/share. Other significant...
News, Short Squeeze, Breakout and More Instantly...
TRxADE (NASDAQ: MEDS) today announced that its board of directors has declared a special cash dividend of $1.50 per share of common stock. According to the announcement, the special dividend is being paid using a portion of the proceeds received in May 2024 in connection with the prior sale of t...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...
TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. ( Nasdaq: MEDS ) (the “ Company ”), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company regained complianc...